Schedule 13G ownership disclosure

APTEVO THERAPEUTICS INC

Security class unavailable · CUSIP: 03835L207

Event date: 2020-11-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-20-021499
Form type
SC 13G
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Nov 16, 2020
Reporting period
Nov 05, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub